Discontinued — last reported Q2 '23
Year-over-year, this metric declined by 100.0%, from $35.07M to $0.00. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -16.0% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.72M | $168.03M | $246.00K | $717.91M | $750.00K | $5.56M | $79.48M | $1.09M | $20.37M | $12.47M | $7.92M | $122.48M | $844.00K | $51.12M | $3.97M | $35.07M | -$704.00K | $67.26M | $0.00 | $0.00 |
| QoQ Change | — | +370.4% | -99.9% | >999% | -99.9% | +640.8% | >999% | -98.6% | >999% | -38.8% | -36.5% | >999% | -99.3% | >999% | -92.2% | +783.5% | -102.0% | >999% | -100.0% | — |
| YoY Change | — | — | — | — | -97.9% | -96.7% | >999% | -99.8% | >999% | +124.4% | -90.0% | >999% | -95.9% | +310.1% | -49.9% | -71.4% | -183.4% | +31.6% | -100.0% | -100.0% |
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 |
|---|---|---|---|---|---|---|---|---|
| CORPORATE AND OTHER | $1.09M | $20.37M | $12.47M | $7.92M | $122.48M | $844.00K | $51.12M | $3.97M |
| GLOBAL DATA CENTER BUSINESS | $1.09M | $20.37M | $12.47M | $7.92M | $122.48M | $844.00K | $51.12M | $3.97M |
| GLOBAL RIM BUSINESS | $1.09M | $20.37M | $12.47M | $7.92M | $122.48M | $844.00K | $51.12M | $3.97M |
| Total | $1.09M | $20.37M | $12.47M | $7.92M | $122.48M | $844.00K | $51.12M | $3.97M |
CORPORATE AND OTHER, GLOBAL DATA CENTER BUSINESS, GLOBAL RIM BUSINESS were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.